When the cell's recycling stations, the lysosomes, start leaking, it can become dangerous. Toxic waste risks spreading and ...
LAS VEGAS, UNITED STATES - Media OutReach Newswire - 7 January 2026 - Amidst a CES 2026 landscape dominated by AI headlines ...
Ultrasound-based treatments, such as Sofwave, use focused ultrasound waves to vibrate and heat the deeper layers of the skin, increasing blood flow, collagen production and repair. They are often ...
A satellite photo from July shows intricate snowy stripes painted across the Atacama Desert in Chile. The icy weather temporarily put the Atacama Large Millimeter/submillimeter Array (ALMA) ...
The FDA has approved omidubicel-onlv (Omisirge, Gamida Cell Ltd.) as the first hematopoietic stem cell transplant therapy for patients with severe aplastic anemia (SAA). Specifically, omidubicel is ...
Dec. 8 (UPI) --The U.S. Food and Drug Administration on Monday announced the approval of the first hematopoietic stem cell transplant therapy to treat patients with rare but severe aplastic anemia.
Study findings showed 86% of patients had early and sustained neutrophil recovery at 100 days. The Food and Drug Administration (FDA) has approved Omisirge ® (omidubicel-onlv) for adults and pediatric ...
What Is Omisirge, and Why Does It Matter? Omisirge (omidubicel-onlv) is a type of cell therapy made from umbilical cord blood. It helps your body make new blood cells after a stem cell transplant.
Ayrmid Ltd. (“Ayrmid” or the “Company”), the parent company of Gamida Cell Inc., a cell therapy pioneer working to turn cells into powerful therapeutics, announced positive interim study results for ...
Charli XCX has got work on the brain. The “360” singer got real about her plastic surgery obsessions in a new Vanity Fair interview, admitting she’s constantly researching cosmetic procedures and ...
Netflix’s forthcoming animated series Tom Clancy’s Splinter Cell: Deathwatch draws from the lore established by Ubisoft’s Splinter Cell games and their canonical ancillary material to tell a new story ...